Hopkins Team Develops Method to Improve Rare Mutation Detection for Early Cancer Dx

The next step in developing Safe-SeqS is to validate the method in a large number of samples from patients with a variety of cancer types as well as normal controls.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.